TrialThe oncologist2024

Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.

Erkut H Borazanci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.